Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Pharmaceutical composition for piperidinoalkanol compounds

United States Patent:  5,932,247

Inventors:  Ortyl; Thomas T. (Overland Park, KS); Skultety; Paul F. (Leawood, KS); Mitchell; Kristen C. (Lee's Summit, MO); Phadke; Deepak S. (Olathe, KS); Attarchi; Faraneh (Kansas City, MO); Pierce; Marguerite L. (Fairway, KS); Schoeneman; Aaron W. (Lee's Summit, MO); Schnitz; Joseph M. (Kansas City, MO)

Assignee:  Hoechst Marion Roussel, Inc. (Cincinnati, OH)

Appl. No.:  948005

Filed:  October 9, 1997

Abstract

The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.

Summary of the Invention

The present invention provides a pharmaceutical composition in solid unit dosage form, comprising,

a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and

b) at least one inert ingredient.

The present invention further provides a pharmaceutical composition prepared by a wet granulation process comprising, preparing the wet granulation wherein a compound of the formula; (see above for the chemical structure) wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, a diluent and a disintegrant are mixed with a solution of a binding agent; the wet granulation is screened; and the wet granulation is dried. In addition, the present invention provides combining the above dry granulation with a lubricant. The present invention further provides pressing the above final mixture into a tablet.

Example 1 of the Patent

20 mg Gelatin Capsules for Oral Administration

Combine 32.4 kg of 4-›4-›4-(Hydroxydiphenylmethyl)-1-piperidinyl-
1-hydroxybutyl-.alpha.,.al pha.-dimethylbenzeneacetic acid hydrochloride with a particle surface area of about 2-4 m.sup.2 /g, 76.1 kg microcrystalline cellulose, 76.1 kg lactose, and 21.6 kg pregelatinized starch and blend in a mixer for 5 minutes. To this mixture, add a solution of 7.9 kg of gelatin in 55.0 kg purified water (prepared by adding the gelatin to the water and heating the dispersion with mixing until solution of the gelatin is attained) and continue mixing until a good granulation is formed. Pass the granulation through a 0.375 inch screen and dry at 60oC. until a moisture content of less than 3.0% is achieved as determined by a Computrac moisture balance at 125oC. Mill the dried granulation through a 0.065 inch screen. To the granulation add 10.8 kg of croscarmellose sodium and mix for about 10 minutes. Fill the granulation into size 3 hard gelatin capsules to a fill weight of 138.9 mg granulation per capsule. This procedure results in about 1,620,000 capsules of the composition shown in table 6 below.

                  TABLE 6
    ______________________________________
    Composition of 20 mg Gelatin Capsules
                     AMOUNT    COMPOSITION
    INGREDIENT       mg/capsule
                               % by weight
    ______________________________________
    Piperidinoalkanol Compound*
                     20.0      14.4
    Microcrystalline Cellulose
                     47.0      33.8
    Lactose          47.0      33.8
    Pregelatinized Starch
                     13.3      9.6
    Croscarmellose Sodium
                     6.7       4.8
    Gelatin          4.9       3.5
    ______________________________________
*4-›4›4(Hydroxydiphenylmethyl)-1-piperidinyl1-
hydroxybutyl.alpha.,dimethy benzeneacetic 
acid hydrochloride with a particle surface area 
of about 2-4 m2 /g.

Claim 1 of 4 Claims

1. A pharmaceutical composition in solid unit dosage form prepared by a process comprising blending together a compound of the formula: 

wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, with microcrystalline cellulose, lactose and pregelatinized starch; adding a solution of gelatin in water mixing; drying and milling the mixture; and adding croscarmellose sodium with mixing, wherein the resulting mixture is filled into capsules.

____________________________________________
If you want to learn more about this patent, please go directly to the US Patent and Trademark Office web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]